Home/Filings/4/0001683168-18-002459
4//SEC Filing

Garnette Sophia 4

Accession 0001683168-18-002459

CIK 0001355790other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 4:57 PM ET

Size

12.6 KB

Accession

0001683168-18-002459

Insider Transaction Report

Form 4
Period: 2018-08-20
Bakalova Sofya
Dir. of Legal Affairs & Oper.
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-08-203,55611,111 total
    Exercise: $1.09Exp: 2027-02-10Common Stock (14,667 underlying)
  • Exercise/Conversion

    Common Stock

    2018-08-20$1.09/sh+3,556$3,8763,823 total
  • Exercise/Conversion

    Common Stock

    2018-08-20$1.10/sh+5,748$6,3239,571 total
  • Sale

    Common Stock

    2018-08-20$1.58/sh9,304$14,700267 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-08-205,74854,252 total
    Exercise: $1.10Exp: 2027-05-31Common Stock (60,000 underlying)
Footnotes (3)
  • [F1]The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share.
  • [F2]The option, representing a total of 20,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on May 10, 2017, and the remaining shares in equal monthly installments over a period of 33 months.
  • [F3]The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months.

Documents

1 file

Issuer

International Stem Cell CORP

CIK 0001355790

Entity typeother

Related Parties

1
  • filerCIK 0001616590

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:57 PM ET
Size
12.6 KB